Continuing Review for Expedited Studies

No longer required for some minimal risk research, including studies where the only remaining activity is analysis of identifiable data/biospecimens or activity to obtain follow-up clinical data.  

Please note: These changes only apply to new studies submitted on/after July 19, 2018.  

You can expect to see the following changes:

1.  IRBNet Smart Form and Supplemental Form Changes
2.  Informed Consent Template and Optional Language Glossary Revisions
3.  IRB Policy Revisions
4.  For existing studies: After the implementation date, the IRBs may choose to apply the new rules to minimize burden for investigators.


  • Check this website periodically for new information.  We will continue to add information as it becomes available.   
  • Look for educational sessions on the IRB Office website.


HHS Final Revisions to Common Rule

Exemptions – AU has decided to adopt the “limited IRB Review” under exemption #2 only.

sIRB - AU IRBs will continue to assess its criteria for whether AU will serve as the single IRB-of-Record or cede review to another institution or a commercial IRB.

Broad Consent - AU is determining if use of broad consent will be adopted under exemptions 7 & 8.

Any changes made to IRBNet documents will still be housed in the IRBNet system under Forms and Templates.